WebDownload DARZALEX FASPRO® Dosing and Administration guide Download DARZALEX® Dosing and Administration guide Patient identification card ID card informing healthcare providers about treatment with DARZALEX FASPRO ® or DARZALEX ® . Download ID card Daratumumab and serologic testing brochure WebApr 3, 2024 · In addition, we can also investigate specialty pharmacies that may be available to simplify product procurement and billing for healthcare providers. If you have questions, please call a Janssen CarePath Care Coordinator at 877-CarePath (877-227-3728), Monday-Friday, 8:00 AM to 8:00 PM ET.
Darzalex IV Infusion: Uses, Taking, Side Effects, Warnings
WebJul 21, 2024 · Providers must bill with HCPCS code: J9999 - Not otherwise classified, antineoplastic drugs One Medicaid and NC Health Choice unit of coverage is: 10 mg The maximum reimbursement rate per unit is: $45.44 Providers must bill 11-digit National Drug Codes (NDCs) and appropriate NDC units. The NDC is: 57894-0503-01 WebMar 14, 2024 · Darzalex is a prescription drug approved to treat multiple myeloma. Learn about the common, mild, and serious side effects it can cause and how to manage them. … biolim internship
Multiple myeloma resources - DARZALEX FASPRO® …
WebOct 1, 2015 · This article contains billing and coding guidelines that complement the Local Coverage Determination (LCD) Drugs and Biologicals, Coverage of, for Label and Off … WebDarzalex (daratumumab) has not been evaluated in patients with moderate to severe hepatic impairment. Mild hepatic impairment and renal impairment do not require … WebDARZALEX ® (daratumumab) is indicated for the treatment of adult patients with multiple myeloma: In combination with lenalidomide and dexamethasone in newly diagnosed … biolily pharmaceutical